Are Blue Badges working for you? Date 25 August 2023 Blue Badges are invaluable, but not everyone living with Parkinson’s who is entitled can get one.
Eye scans detect signs of Parkinson’s up to 7 years before diagnosis Date 22 August 2023 Largest study on retinal imaging in Parkinson’s identifies markers of Parkinson’s in eye scans with the help of artificial intelligence (AI).
Researchers use AI to predict different drivers of Parkinson’s Date 17 August 2023 The AI examined images of brain cells and was able to identify changes in key areas of the cell that are characteristic of the different known mechanisms that cause Parkinson’s.
Government plans to cut NHS waiting times and give people more choice on care Date 9 August 2023 On 4 August, the UK government published a plan to address the NHS care backlog in England and give people more choice in who provides their care. We look at what it could mean for people with Parkinson’s.
Partnership with The Access Group raises almost £1m Date 1 August 2023 Parkinson’s UK was chosen as The Access Group's charity of the year in the UK for 2022/2023.
Join Jon Goodwin as he travels into space Date 25 July 2023 80-year-old Jon Goodwin was diagnosed with Parkinson’s 9 years ago. Next month, he’s travelling into space.
People with Parkinson's help shape new parliamentary report on pharmacy services Date 25 July 2023 In May, 2 people with Parkinson’s shared their experiences of pharmacy services in England. Their views have shaped a new parliamentary report.
MPs hear how disability benefits are failing people with Parkinson’s Date 17 July 2023 On 12 July, 3 All-Party Parliamentary Groups met MPs to highlight the challenges people living with Parkinson’s, multiple sclerosis, Crohn’s and colitis face accessing vital disability support.
Parkinson’s UK publishes new thinking and memory information in collaboration with UCL Date 17 July 2023 Created in collaboration with the Parkinson’s community and University College London (UCL), we’ve published new information on thinking and memory changes for people with Parkinson’s.
Clinical trial results offer hope of a new Parkinson’s treatment for motor symptoms and dyskinesia Date 7 July 2023 Updated trial results show NLX-112 could treat motor symptoms as well as dyskinesia. If further trials are successful, we could have a valuable new Parkinson’s drug by 2030.
